The analysis of Eribulin in patients with unresectable breast cancer, retorospective multicenter study
Not Applicable
- Conditions
- HER2-negative Unresectable breast cancer
- Registration Number
- JPRN-UMIN000014158
- Lead Sponsor
- Kobe City Medical Center General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
none.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival
- Secondary Outcome Measures
Name Time Method